Trexquant Investment’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.24M Sell
93,960
-12,340
-12% -$1.04M 0.04% 630
2026
Q1
$10.6M Buy
106,300
+13,819
+15% +$1.8M 0.08% 362
2025
Q4
$11.3M Buy
92,481
+12,080
+15% +$1.52M 0.1% 272
2025
Q3
$9.02M Sell
80,401
-30,764
-28% -$3.6M 0.09% 337
2025
Q2
$14.9M Buy
+111,165
New +$12.2M 0.17% 143
2024
Q3
Sell
-42,093
Closed -$6.34M 1861
2024
Q2
$6.34M Buy
+42,093
New +$5.05M 0.1% 332
2023
Q4
Sell
-15,133
Closed -$829K 1789
2023
Q3
$829K Sell
15,133
-5,833
-28% -$420K 0.02% 825
2023
Q2
$1.76M Buy
20,966
+5,860
+39% +$449K 0.05% 535
2023
Q1
$1.14M Sell
15,106
-6,691
-31% -$463K 0.03% 685
2022
Q4
$1.35M Buy
+21,797
New +$1.16M 0.04% 538
2020
Q4
Sell
-13,170
Closed -$181K 1480
2020
Q3
$181K Buy
+13,170
New +$226K 0.01% 1101

Other funds holding TMDX

Trexquant Investment's TMDX Position: Q2 2026 in Review

Trexquant Investment reduced its Transmedics (TMDX) stake by 12% in Q2 2026, selling an estimated $1.04M and leaving 93,960 shares worth $6.24M. The position accounts for 0.04% of the portfolio, ranked #630.

Trexquant Investment first reported a position in TMDX in Q3 2020 and has held it in 11 quarters since. The position peaked at $14.9M in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Trexquant Investment held 93,960 shares of Transmedics worth $6.24M as of Q2 2026.
  • Trexquant Investment sold 12,340 Transmedics shares in Q2 2026, an estimated $1.04M.
  • Transmedics made up 0.04% of Trexquant Investment's portfolio in Q2 2026, its #630 holding.
  • Trexquant Investment first reported a position in Transmedics in Q3 2020 and has held it in 11 quarters since.
  • Trexquant Investment's Transmedics position peaked at $14.9M in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.